Effectiveness of stepped depression care among patients with screen-identified depression after acute coronary syndromes: A secondary analysis of the CODIACS-QoL randomized clinical trial
Authors:
- 14 April 2022
- journal article
- letter
- Published by Elsevier in General Hospital Psychiatry
- Vol. 78, 126-127
Abstract
No abstract availableFunding Information
- National Institute of Mental Health (5T32MH013043–50)
- National Heart, Lung, and Blood Institute (R01 HL114924)
- Columbia University
This publication has 8 references indexed in Scilit:
- Effect of Depression Screening After Acute Coronary Syndromes on Quality of LifeJAMA Internal Medicine, 2020
- Rationale, design, and baseline data for a multicenter randomized clinical trial comparing depression screening strategies after acute coronary syndrome: The comparison of depression identification after acute Coronary Syndromes-Quality of Life and Cost Outcomes (CODIACS-QOL) trialContemporary Clinical Trials, 2019
- Diagnostic Accuracy of Screening Tests and Treatment for Post–Acute Coronary Syndrome DepressionAnnals of Internal Medicine, 2017
- Centralized, Stepped, Patient Preference–Based Treatment for Patients With Post–Acute Coronary Syndrome DepressionJAMA Internal Medicine, 2013
- Enhanced Depression Care for Patients With Acute Coronary Syndrome and Persistent Depressive SymptomsArchives of internal medicine (1960), 2010
- Depression and Coronary Heart DiseaseCirculation, 2008
- Screening for depression in medical careJournal of Psychosomatic Research, 2003
- Differences between detected and undetected patients in primary care and depressed psychiatric patientsGeneral Hospital Psychiatry, 1996